Michael Faughnan has been named business development director of Eden Biodesign‘s U.S. subsidiary, Eden Biodesign, Inc. He will support Dr. Roger Lias, president of Eden Biodesign, Inc. and group commercial director, with the company’s expansion in the U.S. and is responsible for North American Business Development activities.
 
Located in southern California, Mr. brings more than 14 years of experience in successfully aiding clients in accelerating their biopharmaceutical products into and through clinical development and to commercial launch, according to a company statement. Said Dr. Lias, “Michael brings tremendous experience and will be an invaluable asset as we continue to build our U.S. infrastructure and expand our services to clients in the North American market.”
 
Most recently, Mr. Faughnan was manager of sales and business development at Cytovance Biologics, where he was responsible for North American commercial activities.  Previously he spent five years as territory manager in the industrial cell culture media division of Irvine Scientific. Prior to that, he was a sales professional at Woodside Biomedical, now part of Abbott Laboratories.